AI Science Tracker

Nanjing Medical University

1 discovery from 2026

Discoveries

Stability-based machine learning selects IL-8 and CCL3 as a two-protein serum signature for early silicosis

A stability-based feature-selection workflow combining LASSO, random forest and SVM recursive feature elimination identified serum IL-8 and CCL3 as a two-protein signature distinguishing Stage I silicosis from controls. The study used a discovery cohort of 57 cases and 57 matched controls, then assessed the signature in an independent, unmatched cohort of 40 cases and 40 controls. The article reports validation AUC 0.973, specificity 95.0% and sensitivity 77.5%; both proteins were lower in silicosis cases.

Technology: Stability-based ensemble feature selection using LASSO, random forest and SVM recursive feature elimination, followed by logistic regression

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: The study used a discovery cohort of 57 cases and 57 matched controls, then assessed the signature in an independent, unmatched cohort of 40 cases and 40 controls.
  • Still unknown: The discovery cohort was small (57 cases/57 matched controls); the validation cohort was also small and unmatched (40/40), with 77.5% sensitivity despite high specificity. This is retrospective biomarker validation and does not establish population screening performance, clinical utility, or causal involvement of IL-8 or CCL3 in silicosis.
  • AI role: Across 100 iterations, the machine-learning feature-selection framework selected a stable two-protein signature from targeted serum proteomics. A logistic-regression classifier used those selected features and was evaluated by cross-validation and an independent validation cohort. The study reports reduced IL-8 and CCL3 as the signature components.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/41937675/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.